Quality and predictors of anticoagulant control with vitamin K antagonist for stroke prevention in atrial fibrillation

Matthew R. Wilson; Ruwan Parakramawansha; Terence J. Quinn; Robert C. Tait

doi:10.1160/TH16-01-0025

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2016; 116(03): 578-580
DOI: 10.1160/TH16-01-0025

Letters to the Editor

Schattauer GmbH

Quality and predictors of anticoagulant control with vitamin K antagonist for stroke prevention in atrial fibrillation

Matthew R. Wilson

¹Department of Haematology, Royal Infirmary, Glasgow, UK

,

Ruwan Parakramawansha

²Department of Clinical Pharmacology, Royal Infirmary, Glasgow, UK

,

Terence J. Quinn

³Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK

,

Robert C. Tait

¹Department of Haematology, Royal Infirmary, Glasgow, UK

³Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK

› Institutsangaben

Abstract

Supplementary Material to this article is available online at www.thrombosis-online.com.

Volltext

Referenzen

References
1 White HD, Gruber M, Feyzi J. et al. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. Arch Intern Med 2007; 167: 239-245.
2 National Institute for Health and Clinical Excellence (NICE). Atrial fibrillation: the management of atrial fibrillation. NICE clinical guideline 180 Issued June 2014; 1-5 2015.
3 Landefeld CS, Goldman L.. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med 1989; 87: 144-152.
4 Costa GL, Lamego RM, Colosimo EA. et al. Identifying potential predictors of high-quality oral anticoagulation assessed by time in therapeutic international normalized ratio range: a prospective, long-term, single-center, observational study. Clin Ther 2012; 34: 1511-1520.
5 Apostolakis S, Sullivan RM, Olshansky B. et al. Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT(2)R(2) score. Chest 2013; 144: 1555-1563.
6 Rose AJ, Hylek EM, Ozonoff A. et al. Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA). J Thromb Haemost 2010; 8: 2182-2191.
7 Rosendaal FR, Cannegieter SC, van der Meer FJ. et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 69: 236-239.
8 Apostolakis S, Sullivan RM, Olshansky B. et al. Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT2R2 score. Chest 2013; 144: 1555-1563.
9 Abdul-Rahim AH, Wong J, McAlpine C. et al. Associations with anticoagulation: a cross-sectional registry-based analysis of stroke survivors with atrial fibrillation. Heart 2014; 100: 557-562.

Zusatzmaterial

Zusatzmaterial